New N95 decontamination process gets FDA approval
The US Food and Drug Administration (FDA) has cleared an N95 decontamination process that enables reuse of the single-use masks to help ease supply shortages.
The emergency use authorisation (EUA) enables the emergency re-use of single use equipment, reports TechCrunch, and may result in as many as four million N95 respirators being sterilised for re-use each day, as medical professionals and frontline workers at healthcare facilities struggle with a shortage of supplies.
This decontamination process uses vaporised hydrogen peroxide gas from sterilisation machines which are already in use in many hospitals for sterilising clinical equipment.
The FDA recently cleared another N95 decontamination – Battelle’s vaporised hydrogen peroxide process.
Duke University in the US demonstrated the safety and effectiveness of the new process.